Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer

Molecular tumor biomarkers hold considerable promise for accurately predicting colorectal cancer (CRC) recurrence and progression. Prokineticin 2 (PROK2) may be associated with angiogenesis and tumor formation in some malignant tumors. However, its prognostic value remains unknown. We focused on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Yu, Goi, Takanori, Kurebayashi, Hidetaka, Morikawa, Mitsuhiro, Hirono, Yasuo, Katayama, Kanji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059027/
https://www.ncbi.nlm.nih.gov/pubmed/30046389
http://dx.doi.org/10.18632/oncotarget.25706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059027/
https://www.ncbi.nlm.nih.gov/pubmed/30046389
http://dx.doi.org/10.18632/oncotarget.25706

Ejemplares similares